{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:48:10Z","timestamp":1769856490527,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.vph.2015.06.016","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T17:40:28Z","timestamp":1436031628000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and Multidrug Resistance Protein 4 expression in human platelets"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1288-4117","authenticated-orcid":false,"given":"Flavia","family":"Temperilli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Di Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Massimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Paola","family":"Guzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Valesini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Frati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2595-396X","authenticated-orcid":false,"given":"Fabio M.","family":"Pulcinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2015.06.016_bb0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tips.2008.01.006","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4): a versatile efflux transporter for drugs and signalling molecules","volume":"29","author":"Russel","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.vph.2015.06.016_bb0010","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2011.03.049","article-title":"Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting","volume":"58","author":"Mattiello","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.vph.2015.06.016_bb0015","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/bcp.12432","article-title":"Aspirin influences megakaryocytic gene expression leading to upregulation of Multidrug Resistance Protein-4 in human platelets","volume":"78","author":"Massimi","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.vph.2015.06.016_bb0020","first-page":"w13071","article-title":"Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels","volume":"140","author":"Yessoufou","year":"2010","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.vph.2015.06.016_bb0025","doi-asserted-by":"crossref","first-page":"22067","DOI":"10.1074\/jbc.M109.085118","article-title":"Leukotriene B4 is a physiologically relevant endogenous peroxisome proliferator-activated receptor-alpha agonist","volume":"285","author":"Narala","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2015.06.016_bb0030","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1124\/dmd.106.013839","article-title":"Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha","volume":"35","author":"Ng","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.vph.2015.06.016_bb0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1476-5381.1989.tb11812.x","article-title":"Prostaglandin E2 inhibits and indomethacin and aspirin enhance, A23187-stimulated leukotriene B4 synthesis by rat peritoneal macrophages","volume":"96","author":"Elliott","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2015.06.016_bb0040","first-page":"823","article-title":"Failure of apoptosis and activation on NFkappaB by celecoxib and aspirin in lung cancer cell lines","volume":"17","author":"Gradilone","year":"2007","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.vph.2015.06.016_bb0045","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood.V72.6.1968.1968","article-title":"Characterization of a new megakaryocytic cell line: the Dami cell","volume":"72","author":"Greenberg","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.vph.2015.06.016_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0014-5793(95)00352-A","article-title":"Protein kinase C activation is not a key step in ADP-mediated exposure of fibrinogen receptors on human platelets","volume":"364","author":"Pulcinelli","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.vph.2015.06.016_bb0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.109.928192","article-title":"Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study","volume":"122","author":"Freedman","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.06.016_bb0060","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1073\/pnas.0401901101","article-title":"Neutrophils alter the inflammatory milieu by signal-dependent translation of constitutive messenger RNAs","volume":"101","author":"Lindemann","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2015.06.016_bb0065","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/gcc.20913","article-title":"Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women","volume":"50","author":"Passarelli","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.vph.2015.06.016_bb0070","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/194927b0","article-title":"The aggregation of blood platelets by adenosine diphosphate and its reversal","volume":"194","author":"Born","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.vph.2015.06.016_bb0075","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2015.06.016_bb0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2014.05.001","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4) regulates thrombus formation in vitro and in vivo","volume":"737","author":"Lien","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2015.06.016_bb0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/hrt.2006.089367","article-title":"The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction","volume":"93","author":"Brophy","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.vph.2015.06.016_bb0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/clpt.2008.204","article-title":"Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study","volume":"85","author":"Fosbol","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.vph.2015.06.016_bb0095","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.106.616219","article-title":"Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction","volume":"113","author":"Gislason","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.06.016_bb0100","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","article-title":"Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association","volume":"115","author":"Antman","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.06.016_bb0105","doi-asserted-by":"crossref","first-page":"e1001098","DOI":"10.1371\/journal.pmed.1001098","article-title":"Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies","volume":"8","author":"McGettigan","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.vph.2015.06.016_bb0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2015.06.016_bb0115","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJMp048288","article-title":"Coxibs and cardiovascular disease","volume":"351","author":"Fitzgerald","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2015.06.016_bb0120","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1160\/TH12-04-0232","article-title":"Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport","volume":"108","author":"Borgognone","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2015.06.016_bb0125","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/bcp.12335","article-title":"Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects","volume":"78","author":"Floyd","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.vph.2015.06.016_bb0130","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jacc.2013.05.073","article-title":"Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events","volume":"62","author":"Voora","year":"2013","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115001470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115001470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T15:55:41Z","timestamp":1599234941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189115001470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":26,"alternative-id":["S1537189115001470"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2015.06.016","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and Multidrug Resistance Protein 4 expression in human platelets","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2015.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}